The company 410 Medical Inc. http://410medical.com, a medical device company focused on developing innovative technologies for the resuscitation of critically ill patients, has received $2.1 million in additional funding for their Series A financing bringing the Series A total to $5.3 million.
Dr. Mark Piehi, Pediatric Intensive Care Physician at WakeMed Children’s Hospital is the Founder and Chief Medical Officer at 410 Medical. He created the technology called LifeFlow as an alternative to standard fluid infusion devices used in critically ill patients who need rapid fluid resuscitation.
New investors in the Triangle Venture Alliance (TVA), formed the alliance to work with angel networks at Duke University, North Carolina State University, North Carolina Central University, and the University of North Carolina at Chapel Hill.
TVA’s funding for 410 Medical is the first investment made by TVA and will further support the commercialization of the LifeFlow Rapid Infuser. LifeFlow cleared by FDA in 2016 is an easy-to-use device that allows for the rapid delivery of fluids in patients with sepsis, shock, or other emergency conditions.
Based on the positive feedback and the early success of the limited market release, 410 Medical is currently expanding LifeFlow’s release to hospitals and emergency medical services organizations nationwide.
“The company 410 Medical started in North Carolina and LifeFlow is manufactured in the state. By adding UNC, Duke, and NC State through the TVA to our investor syndicate further strengthens our foundation in North Carolina and expands our access to an exceptional network of clinicians, investors, and other professionals”, reports Kyle Chenet, President and CEO of 410 Medical.